Free shipping on all orders over $ 500

PD0166285

Cat. No. M9208

All AbMole products are for research use only, cannot be used for human consumption.

PD0166285 Structure
Synonym:

PD166285

Size Price Availability Quantity
10mM*1mL USD 167 In stock
5mg USD 147 In stock
10mg USD 237 In stock
25mg USD 535 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

PD0166285 is identified to inhibit Wee1 activity at nanomolar concentrations. The inhibitor abrogates G2/M checkpoint inducing early cell division. This G2 checkpoint abrogation by PD0166285 was demonstrated to kill cancer cells, there at a toxic highest dose of 0.5 muM in some cell lines for exposure periods of no longer than 6 hours. PD0166285 does not inhibit Cdc2/cyclin B but inhibits Chk1 kinase at a much higher concentration (3433 nM). 

In vivo, PD0166285 at 0.5 μM concentration can inhibit Cdc2Y15/T14 phosphorylation in all cell lines tested, regardless of their p53 status and pharmacological targeting of WEE1 by PD0166285 sensitizes U251-FM GBM tumors to IR in vivo.

Protocol (for reference only)
Cell Experiment
Cell lines B16 mouse melanoma cells
Preparation method B16 cells (1 × 105 cells in 100 mm-dishes) are maintained in medium overnight. In addition, the cells are treated with (0, 0.5, 1.0, or 2.0 μM) PD0166285 (including DMSO vehicle) for indicated times. The cells are washed twice with phosphate-buffered saline (PBS). Next, the cells are trypsinized, so the cell numbers in each dish are determined by using a computed cell-counter (Sysmex CDA-500) according to manufacturer's recommendation.
Concentrations 0.5, 1, 2 μM
Incubation time 4 h, 24 h
Animal Experiment
Animal models Nude mice with implanted GBM cells
Formulation DMSO
Dosages 0, 20, 100, 200, or 400 µM in 100 µl
Administration s.c.
Chemical Information
Molecular Weight 512.43
Formula C26H27Cl2N5O2
CAS Number 185039-89-8
Solubility (25°C) DMSO: ≥ 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Mir SE, et al. Cancer Cell. In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma.

[2] Hashimoto O, et al. BMC Cancer. Cell cycle regulation by the Wee1 inhibitor PD0166285, pyrido [2,3-d] pyimidine, in the B16 mouse melanoma cell line.

[3] Wang Y, et al. Cancer Res. Radiosensitization of p53 mutant cells by PD0166285, a novel G(2) checkpoint abrogator.

Related Checkpoint Products
AZD7762

AZD7762 is a potent ATP-competitive checkpoint kinase inhibitor with an IC50 of 5 and <10 nM for CHK1 and CHK2 respectively.

BIBR1532

BIBR1532 is a potent and selective telomerase inhibitor with IC50 of 100 nM. BIBR 1532 inhibits the proliferation of JVM13 leukemia cells with an IC50 of 52 μM, and similar effect also occurs in other leukemia cell lines such as Nalm-1, HL-60, and Jurkat. BIBR1532 is also an inhibitor of TERT, the rate-limiting enzyme in the regulation of telomerase activity.

PF-477736

PF-477736 is a selective checkpoint kinase 1 (Chk1) inhibitor with Ki values of 0.49 nM and 47 nM for CHK1 and CHK2 respectively.

SCH 900776

SCH 900776 (MK-8776) is a highly potent and functionally selective CHK1 inhibitor with IC50 of 3 nM.

Rabusertib (LY2603618)

Rabusertib (LY2603618) is an effective and selective Chk1 inhibitor with an IC50 of 7 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: PD0166285, PD166285 supplier, Checkpoint, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.